Another American study by Elsonet al. (2020) explored the outcomes of receiving DTC-GT results for the two most common genetic risk factors for venous thromboembolism (Factor V Leiden and prothrombin 20210G>A). The gene discussed is F2; the disease is venous thromboembolism.